Scarica l'app Stockscreener
11.52
4.54%
0.50
Precedente Chiudi:
$11.02
Aprire:
$11
Volume 24 ore:
1.81M
Relative Volume:
0.76
Capitalizzazione di mercato:
$739.86M
Reddito:
$161.10M
Utile/perdita netta:
$-308.60M
Rapporto P/E:
-2.4668
EPS:
-4.67
Flusso di cassa netto:
$-259.90M
1 W Prestazione:
+8.99%
1M Prestazione:
+19.25%
6M Prestazione:
+84.32%
1 anno Prestazione:
-54.12%
Intervallo 1D:
$10.98
$11.73
Intervallo di 1 settimana:
$10.42
$14.22
Portata 52W:
$5.90
$27.00
Arvinas Inc Stock (ARVN) Company Profile
Nome
Arvinas Inc
Settore
Industria
Telefono
203-535-1456
Indirizzo
395 WINCHESTER AVE, NEW HAVEN, CT
Confronta ARVN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARVN
Arvinas Inc
|
11.52 | 707.75M | 161.10M | -308.60M | -259.90M | -4.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Arvinas Inc Stock (ARVN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-15 | Downgrade | Goldman | Neutral → Sell |
| 2025-09-24 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-09-17 | Ripresa | Barclays | Overweight |
| 2025-06-02 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-05-05 | Downgrade | Truist | Buy → Hold |
| 2025-05-02 | Downgrade | Jefferies | Buy → Hold |
| 2025-05-02 | Downgrade | TD Cowen | Buy → Hold |
| 2025-03-13 | Downgrade | Goldman | Buy → Neutral |
| 2025-03-12 | Downgrade | Wedbush | Outperform → Neutral |
| 2025-03-11 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-12-10 | Iniziato | BTIG Research | Buy |
| 2024-11-18 | Iniziato | Stephens | Overweight |
| 2024-02-28 | Reiterato | Oppenheimer | Outperform |
| 2024-02-14 | Downgrade | Citigroup | Buy → Neutral |
| 2024-02-01 | Iniziato | Goldman | Buy |
| 2023-12-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-12-06 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-11-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2023-10-23 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2023-06-26 | Ripresa | Oppenheimer | Outperform |
| 2023-01-12 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-01-03 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-09-09 | Iniziato | Barclays | Overweight |
| 2022-06-21 | Iniziato | Jefferies | Hold |
| 2022-05-09 | Downgrade | Wedbush | Outperform → Neutral |
| 2022-04-28 | Iniziato | Credit Suisse | Outperform |
| 2022-04-06 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-02-11 | Ripresa | BMO Capital Markets | Outperform |
| 2022-02-10 | Iniziato | Wells Fargo | Overweight |
| 2022-01-19 | Iniziato | Goldman | Buy |
| 2021-12-07 | Iniziato | Cowen | Outperform |
| 2021-10-14 | Iniziato | SVB Leerink | Outperform |
| 2021-09-30 | Iniziato | Stifel | Buy |
| 2021-09-09 | Iniziato | BofA Securities | Buy |
| 2021-05-21 | Iniziato | UBS | Buy |
| 2021-04-21 | Iniziato | Truist | Buy |
| 2021-03-31 | Iniziato | BMO Capital Markets | Outperform |
| 2020-12-14 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2020-06-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-05-12 | Iniziato | Oppenheimer | Perform |
| 2019-12-19 | Iniziato | H.C. Wainwright | Buy |
| 2019-11-25 | Iniziato | Guggenheim | Buy |
| 2019-10-24 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-09-25 | Iniziato | Wedbush | Outperform |
| 2019-09-12 | Iniziato | BMO Capital Markets | Outperform |
| 2019-08-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-05 | Downgrade | Citigroup | Buy → Neutral |
| 2019-04-12 | Iniziato | Evercore ISI | Outperform |
| 2018-10-22 | Iniziato | Citigroup | Buy |
| 2018-10-22 | Iniziato | Goldman | Neutral |
| 2018-10-22 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Arvinas Inc Borsa (ARVN) Ultime notizie
Promising Biotech Stocks To ConsiderNovember 18th - MarketBeat
Can Arvinas Inc. stock beat market expectations this quarterTrend Reversal & Fast Exit/Entry Strategy Plans - newser.com
Arvinas (NASDAQ:ARVN) Stock Price Down 7%Should You Sell? - MarketBeat
Why Arvinas Inc. stock attracts high net worth investorsRate Cut & High Win Rate Trade Tips - newser.com
Is Arvinas Inc. stock attractive after correctionJuly 2025 Technicals & Long-Term Safe Investment Ideas - newser.com
Connor Clark & Lunn Investment Management Ltd. Takes Position in Arvinas, Inc. $ARVN - MarketBeat
Arvinas Inc. stock chart pattern explainedSell Signal & Technical Pattern Recognition Alerts - newser.com
Is Arvinas Inc. still worth holding after the dipFed Meeting & Target Return Focused Stock Picks - newser.com
Arvinas Inc. (ARVN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Arvinas Inc. stock a top pick in earnings seasonJuly 2025 Earnings & Long-Term Safe Return Strategies - newser.com
Reversal indicators forming on Arvinas Inc. stockWeekly Stock Summary & AI Forecast Swing Trade Picks - newser.com
How Arvinas Inc. stock benefits from strong dollarForecast Cut & Real-Time Market Trend Scan - newser.com
Can Arvinas Inc. stock beat analyst upgradesQuarterly Performance Summary & Expert Curated Trade Ideas - newser.com
Arvinas (NASDAQ:ARVN) Shares Gap UpShould You Buy? - MarketBeat
Can technical indicators confirm Arvinas Inc.’s reversalJuly 2025 Macro Moves & Free Daily Entry Point Trade Alerts - newser.com
Arvinas, Inc.Common Stock (NQ: ARVN - FinancialContent
Arvinas’ Stock Surge: Analyzing the Movement - StocksToTrade
Revisiting the Narrative for Arvinas as Analyst Views Shift with New Pipeline and Partner Risks - Yahoo Finance
Is Arvinas Inc. stock affected by interest rate hikesSell Signal & Reliable Price Action Trade Plans - newser.com
Arvinas, Inc. (NASDAQ:ARVN) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Will Arvinas Inc. stock outperform tech sector in 2025Trade Signal Summary & Safe Entry Momentum Stock Tips - newser.com
Has Arvinas Inc. formed a bullish divergence2025 Growth vs Value & Daily Stock Trend Reports - newser.com
Arvinas (NASDAQ:ARVN) Trading 8% HigherHere's Why - MarketBeat
Historical volatility pattern of Arvinas Inc. visualizedWeekly Stock Summary & Proven Capital Preservation Methods - newser.com
How to escape a deep drawdown in Arvinas Inc.Weekly Trade Recap & Daily Risk Controlled Trade Plans - newser.com
Published on: 2025-11-15 14:53:07 - newser.com
Quinn Opportunity Partners LLC Invests $524,000 in Arvinas, Inc. $ARVN - MarketBeat
Arvinas Inc Azioni (ARVN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):